Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical "two-hit" model

Journal of Dental Research

Volumn 85, Issue 2, 2006, Pages 102-105

  Golub, L M ^a   Payne, J B ^b   Reinhardt, R A ^b   Nieman, G ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Hypothetical model; Periodontitis; Systemic diseases

Indexed keywords

ANTIINFECTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEINASE INHIBITOR;

ANIMAL; BIOLOGICAL MODEL; CHRONIC DISEASE; HUMAN; PERIODONTITIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RHEUMATOID ARTHRITIS; TOOTH PLAQUE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BONE DENSITY CONSERVATION AGENTS; CHRONIC DISEASE; DENTAL PLAQUE; DIPHOSPHONATES; HUMANS; MODELS, BIOLOGICAL; OSTEOPOROSIS, POSTMENOPAUSAL; PERIODONTITIS; PROTEASE INHIBITORS;

EID: 33744810316     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910608500201     Document Type: Review

References (44)

1. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, et al. (2003). Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579-1585.
2. Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, et al. (2005). Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 52:2015-2025.
3. Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM (2004). Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol 24:733-738.
4. Carney DE, Lutz CJ, Picone AL, Gatto LA, Ramamurthy NS, Golub LM, et al (1999). Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 100:400-406.
5. Cenci S, Toraldo G, Weitzmann MN, Roggia C, Gao Y, Qian WP, et al. (2003). Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Acad Sci USA 100:10405-10410.
6. Choi BK, Moon SY, Cha JH, Kim KW, Yoo YJ (2005). Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J Periodontol 76:813-820.
7. Craig RG, Yip JK, So MK, Socransky SS, Haffajee AD (2003). Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 74:1007-1016.
8. D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, et al. (2004). Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83:156-160.
9. Elliott J, Paulsen GA, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, et al. (2003). Treatment of early sero-positive rheumatoid arthritis: doxycycline with methotrexate versus methotrexate alone (abstract). Arthritis Rheum 48(Suppl):S1708.
10. Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U (2003). Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 38:198-203.
11. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T (1998). Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12-26.
12. Golub LM, Ramamurthy NS, Llavaneras A, Ryan ME, Lee HM, Liu Y, et al. (1999). A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann NY Acad Sci 878:290-310.
13. Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, et al. (1998). Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 25:1282-1289.
14. Greenwald RA, Kirkwood K (1999). Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies). J Rheumatol 26:1650-1653.
15. Greenwald RA, Moak SA, Ramamurthy NS, Golub LM (1992). Tetracyclines suppress metalloproteinase activity in adjuvant arthritis and, in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 19:927-938.
16. Haynes DR (2004). Bone lysis and inflammation. Inflamm Res 53:596-600.
17. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL (2000). The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2-12.
18. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, et al. (1992). Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91.
19. Kasser UR, Gleissner C, Dehne F, Michel A, Willershausen-Zonnchen B, Bolten WW (1997). Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 40:2248-2251.
20. Kent LW, Rahemtulla F, Michalek SM (1999). Interleukin (IL)-1 and Porphyromonas gingivalis lipopolysaccharide stimulation of IL-6 production by fibroblasts derived from healthy or periodontally diseased human gingival tissue. J Periodontol 70:274-282.
21. Kimble RB, Bain S, Pacifici R (1997). The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935-941.
22. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R (1994). Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94:2397-2406.
23. Krall EA, Garcia RI, Dawson-Hughes B (1996). Increased risk of tooth loss is related to bone loss at the whole body, hip, and spine. Calcif Tissue Int 59:433-437.
24. Lavnikova N, Laskin DL (1995). Unique patterns of regulation of nitric oxide production in fibroblasts. J Leukoc Biol 58:451-458.
25. Lotz M, Blanco FJ, von Kempis J, Dudler J, Maier R, Villiger PM, et al. (1995). Cytokine regulation of chondrocyte functions. J Rheumatol 43(Suppl):104-108.
26. McGee JM, Tucci MA, Edmundson TP, Serio CL, Johnson RB (1998). The relationship between concentrations of proinflammatory cytokines within gingiva and the adjacent sulcular depth. J Periodontol 69:865-871.
27. Miranda LA, Fischer RG, Sztajnbok FR, Figueredo CM, Gustafsson A (2003). Periodontal conditions in patients with juvenile idiopathic arthritis. J Clin Periodontol 30:969-974.
28. Miranda LA, Fischer RG, Sztajnbok FR, Johansson A, Figueredo CM, Gustafsson A (2005). Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss. J Periodontol 76:75-82.
29. Nanes MS (2003). Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321:1-15.
30. Pacifici R (1996). Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051.
31. Patrick DA, Moore FA, Moore EE, Barnett CC Jr, Silliman CC (1996). Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz 4:194-210.
32. Payne JB, Reinhardt RA (1998). Potential application of low-dose doxycycline to treat periodontitis in post-menopausal women. Adv Dent Res 12:166-169.
33. Payne JB, Reinhardt RA, Nummikoski PV, Patil KD (1999). Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int 10:34-40.
34. Ramamurthy NS, Rifkin BR, Greenwald RA, Xu JW, Liu Y, Turner G, et al. (2002). Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. J Periodontol 73:726-734.
35. Ramamurthy NS, Greenwald RA, Celiker MY, Shi EY (2005). Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 76:229-233.
36. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002). Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557-1565.
37. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, et al. (2001). Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98:13960-13965.
38. Ryan ME, Carnu O, Kamer A (2003). The influence of diabetes on the periodontal tissues. J Am Dent Assoc 134:345-405.(AQ)
39. Soory M (2002). Hormone mediation of immune responses in the progression of diabetes, rheumatoid arthritis and periodontal diseases. Curr Drug Targets Immune Endocr Metabol Discord 2:13-25.
40. Steinberg J, Halter J, Schiller H, Gatto L, Nieman G (2005a). The development of acute respiratory distress syndrome after gut ischemia/reperfusion injury followed by fecal peritonitis in pigs: a clinically relevant model. Shock 23:129-137.
41. Steinberg J, Halter J, Schiller H, Gatto L, Carney D, Lee HM, et al. (2005b). Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model. Shock 24:348-356.
42. Uitto VJ, Airola K, Vaalamo M, Johannson N, Putnins EE, Firth JD, et al. (1998). Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 152:1489-1499.
43. Vreugdenhil G, Lowenberg B, van Eijk HG, Swaak AJ (1990). Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis. Rheumatol Int 10:127-130.
44. Yilmaz M, Kendirli SG, Altintas D, Bingol G, Antmen B (2001). Cytokine levels in serum of patients with juvenile rheumatoid arthritis. Clin Rheumatol 20:30-35.